Literature DB >> 20621704

Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector.

Takanori Kanazawa1, Yuuki Takashima, Toshiaki Tamura, Miki Tsuchiya, Yasunori Shibata, Haruhide Udagawa, Hiroaki Okada.   

Abstract

The vaginal mucosa is the most common site of initiation of virus infections that are transmitted through heterosexual intercourse, including HIV and papillomavirus. Thus, in order to prevent or treat these infections, strong vaginal immunity is required as the first line of defense. In this study, to establish a less invasive, safe, convenient and effective immunization method, we examined the local (skin and vagina) gene transfection efficiency of a non-needle jet injector for daily insulin injection. In the skin experiment, the needle-free injector resulted in a marked increase in marker gene expression, compared to the conventional needle-syringe injection. In addition, intradermal DNA vaccination using the needle-free injector dramatically induced IFN-gamma and antibody systemic responses in mice. Furthermore, we investigated the applicability of the needle-free injector as a vaginal vaccination tool in rabbits. Vaginal gene expression using the needle-free injector was significantly greater than that using needle-syringe injection. Moreover, intravaginal vaccination by the needle-free injector promoted vaginal IgA secretion and IFN-gamma mRNA expression in the blood lymphocytes, to a degree significantly higher than that by needle-syringe injection. In conclusion, local vaginal DNA vaccination using a needle-free jet injector is a promising approach for the prevention and treatment of mucosal infectious diseases. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621704     DOI: 10.1016/j.ijpharm.2010.05.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.

Authors:  Guocai Li; Hongmei Jiao; Guihua Jiang; Jing Wang; Litian Zhu; Rushan Xie; Hua Yan; Hongju Chen; Mingchun Ji
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

Review 2.  Vaginal delivery of vaccines.

Authors:  Hannah M VanBenschoten; Kim A Woodrow
Journal:  Adv Drug Deliv Rev       Date:  2021-09-01       Impact factor: 15.470

3.  HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity.

Authors:  Tam Nguyen-Hoai; Dennis Kobelt; Oliver Hohn; Minh D Vu; Peter M Schlag; Bernd Dörken; Steven Norley; Martin Lipp; Wolfgang Walther; Antonio Pezzutto; Jörg Westermann
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

Review 4.  Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Authors:  Kazuhiko Matsuo; Sachiko Hirobe; Naoki Okada; Shinsaku Nakagawa
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

5.  Electromagnetic Force-Driven Needle-Free in Ovo Injection Device.

Authors:  Ko-Jung Huang; Cheng-Han Li; Ping-Kun Tsai; Chia-Chun Lai; Yu-Ren Kuo; Ming-Kun Hsieh; Ching-Wei Cheng
Journal:  Vet Sci       Date:  2022-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.